Cynthia Lynn Anderson Vista Gen Therapeutics, Inc. (VTGN) insider trading activity

VTGN Quotes by TradingView

Cynthia Lynn Anderson is CHIEF FINANCIAL OFFICER of VistaGen Therapeutics, Inc.. Currently has a direct ownership of 6,184 shares of VTGN, which is worth approximately $17,871. The most recent transaction as insider was on Dec 31, 2024, when has been sold 2,592 shares (Common Stock) at a price of $2.51 per share, resulting in proceeds of $6,505. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 6.18K
72.16% 3M change
n/a 12M change
Total Value Held $17,871

Cynthia Lynn Anderson Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 31 2024
BUY
Grant, award, or other acquisition
$6,505 $2.51 p/Share
2,592 Added 29.54%
6,184 Common Stock
Jun 28 2024
BUY
Grant, award, or other acquisition
$10,632 $2.96 p/Share
3,592 Added 50.0%
3,592 Common Stock
CLA

Cynthia Lynn Anderson

CHIEF FINANCIAL OFFICER
South San Francisco, CA

Track Institutional and Insider Activities on VTGN

Follow VistaGen Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VTGN shares.

Notify only if

Insider Trading

Get notified when an Vista Gen Therapeutics, Inc. insider buys or sells VTGN shares.

Notify only if

News

Receive news related to VistaGen Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on VTGN